Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Coeptis Therapeutics (NASDAQ:COEP) through any online brokerage.
Other companies in Coeptis Therapeutics’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), Korro Bio (NASDAQ:KRRO) and ABVC BioPharma (NASDAQ:ABVC).
Coeptis Therapeutics has a consensus price target of $5.67.
The stock price for Coeptis Therapeutics (NASDAQ: COEP) is $15 last updated November 13, 2025 at 9:28 AM EST.
There are no upcoming dividends for Coeptis Therapeutics.
Coeptis Therapeutics’s Q3 earnings are confirmed for Tuesday, November 25, 2025.
There is no upcoming split for Coeptis Therapeutics.
Coeptis Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.